SCHEMBL6174341

SCHEMBL6174341

CCOc1cccc(NC(=O)c2cccnc2)c1

nearest known ligand 0.82

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.75
SMN1; SMN2 Q16637 2/20 0.75
KMT2A Q03164 3/20 0.70
CYP1A2 P05177 1/20 0.70
CYP2C9 P11712 1/20 0.70
HTT P42858 2/20 0.67
LMNA P02545 2/20 0.67
MAPK1 P28482 1/20 0.67
KDR P35968 1/20 0.66
ALDH1A1 P00352 3/20 0.65
KDM4E B2RXH2 2/20 0.65
NR1H4 Q96RI1 1/20 0.64
KCNK3 O14649 1/20 0.64
MAPT P10636 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5215050 0.88 KMT2A (0.59) TSHRSMN1; SMN2KMT2ACYP1A2CYP2C9
SCHEMBL4653584 0.86 SMN1; SMN2 (1.00) TSHRSMN1; SMN2KMT2ACYP1A2CYP2C9
SCHEMBL10294799 0.84 KMT2A (0.78) TSHRSMN1; SMN2KMT2AHTTLMNA
SCHEMBL22983352 0.82 ALDH1A1 (0.84) TSHRSMN1; SMN2KMT2ACYP1A2CYP2C9
SCHEMBL27989071 0.82 KMT2A (0.62) TSHRSMN1; SMN2KMT2AHTTLMNA
SCHEMBL29927602 0.81 TSHR (0.62) TSHRSMN1; SMN2KMT2ACYP1A2CYP2C9
SCHEMBL29927042 0.81 TSHR (0.61) TSHRSMN1; SMN2KMT2ACYP1A2CYP2C9
SCHEMBL24933360 0.81 RAB9A (0.73) TSHRSMN1; SMN2KMT2ACYP1A2CYP2C9
SCHEMBL6174665 0.80 KMT2A (0.73) TSHRSMN1; SMN2KMT2ACYP1A2CYP2C9
SCHEMBL259177 0.79 TDP1 (0.78) TSHRSMN1; SMN2KMT2ACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575918-A2 SUBSTITUTED BIARYL-4-CARBOXYLIC ACID ARYLAMIDE ANALOGUES AS CAPSAICIN RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2005-09-21 EP claimed
WO-2004056774-A2 SUBSTITUTED BIPHENYL-4-CARBOXYLIC ACID ARYLAMIDE ANALOGUES AS CAPSAICIN RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2004-07-08 WO claimed